Yan Yang

Title: Yan Yang: Innovator in Cancer Treatment

Introduction

Yan Yang is a prominent inventor based in Hamden, CT, known for his significant contributions to the field of cancer treatment. With a total of two patents to his name, Yang has focused on developing innovative solutions that target receptor tyrosine kinases, which play a crucial role in cancer progression.

Latest Patents

Yang's latest patents include "Anti-MET antibodies and methods of use thereof" and "Inhibitors of receptor tyrosine kinases and methods of use thereof." The first patent provides compositions and methods involving antibodies that specifically bind to MET, a receptor tyrosine kinase, and modulate its expression and activity. This invention offers potential methods for managing, treating, or preventing disorders such as cancer. It includes a monoclonal antibody that binds to the Sema/PSI domain of human MET and outlines a method for administering a therapeutically effective amount of the antibody to subjects in need. The second patent presents moieties that bind to an Ig-like domain of human receptor tyrosine kinases, locking the ectodomain in an inactive state and thereby antagonizing the activity of these kinases.

Career Highlights

Throughout his career, Yan Yang has worked with esteemed institutions such as Yale University and Celldex Therapeutics Limited. His work has significantly advanced the understanding and treatment of cancer, showcasing his dedication to medical innovation.

Collaborations

Yang has collaborated with notable colleagues, including Joseph Schlessinger and Irit Lax, who have contributed to his research endeavors and innovations in the field.

Conclusion

Yan Yang's contributions to cancer treatment through his innovative patents and collaborations highlight his role as a leading inventor in the medical field. His work continues to pave the way for advancements in therapeutic strategies against cancer.